Prostate Screening Tests Used Even if They Don’t Provide Value
Shifting guidelines for prostate cancer screening lead to uncertainty on when and if prostate screening tests should be ordered.
Read MorePosted by Chris Wolski | Jan 5, 2023 | Prostate |
Shifting guidelines for prostate cancer screening lead to uncertainty on when and if prostate screening tests should be ordered.
Read MorePosted by Andy Lundin | Jan 3, 2023 | Unknown Origin & Other Cancer Types |
The FDA granted Datar Cancer Genetics Breakthrough Device Designation for its TriNetra-Glio test, a liquid biopsy to diagnose brain tumors.
Read MorePosted by Andy Lundin | Dec 15, 2022 | Prostate |
Researchers pioneered and implemented a novel algorithm to provide genetic testing to patients with newly diagnosed prostate cancer.
Read MorePosted by Chris Wolski | Dec 15, 2022 | Analytical Software Systems, Prostate |
Ibex Medical Analytics announced the live deployment by the University of Pittsburgh Medical Center (UPMC) of Galen Prostate.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Prostate |
Cambridge scientists have created a comprehensive tool for predicting an individual’s risk of developing prostate cancer.
Read More